Clinical Trial Update: A Clinical Trial of Envafolimab Combined With Lenvatinib for Kidney Cancer With Liver Spread [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update indicates a study of Envafolimab in combination with Lenvatinib for clear cell renal cell carcinoma with liver metastases, curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clear Cell Renal Cell Carcinoma
• Liver Metastases

Drugs mentioned

• Envafolimab (envafolimab)
• Lenvatinib (lenvatinib)

Snippet

Sponsor: Fudan University | Conditions: Clear Cell Renal Cell Cancer (ccRCC), Liver Metastasis | Phase 2 | Status: NOT_YET_RECRUITING